Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : HOTH save search
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 5.37%
H: 0.64%
C: -12.1%
obesity treatment wholly
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
Published: 2024-03-27 (Crawled : 18:00) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 1.45%
H: 8.57%
C: 8.57%
million therapeutics
Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ
Published: 2024-03-19 (Crawled : 15:30) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 21.74%
H: 19.29%
C: -3.57%
disease pre-clinical positive treatment alzheimer's therapeutics ht-alz study
Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: -2.31%
H: 4.72%
C: -3.15%
patent therapeutics
Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic
Published: 2024-02-26 (Crawled : 15:30) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: -2.7%
H: 6.35%
C: 1.59%
cancer key therapeutics perform study
Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024
Published: 2024-02-13 (Crawled : 18:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: -0.73%
H: 5.15%
C: 2.94%
ceo therapeutics
Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients
Published: 2024-01-18 (Crawled : 00:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 5.43%
H: 13.24%
C: 0.74%
ht-001 fda approval treat trial therapeutics
Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami
Published: 2023-12-27 (Crawled : 13:30) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 16.3%
H: 10.19%
C: 2.55%
ht-001 fda cleared cancer expansion trial therapeutics
Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies
Published: 2023-12-05 (Crawled : 13:30) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 0.0%
H: 12.1%
C: 4.84%
cancer therapeutics
Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT
Published: 2023-11-14 (Crawled : 13:30) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 6.19%
H: 3.33%
C: -6.67%
fda cancer meeting therapeutics
Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023
Published: 2023-11-10 (Crawled : 13:00) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.47%
therapeutics growth
Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery
Published: 2023-10-05 (Crawled : 14:30) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 2.9%
H: 16.2%
C: -2.11%
drug initiative therapeutics
FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients
Published: 2023-10-02 (Crawled : 13:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 5.9%
H: 0.0%
C: -7.45%
fda cancer treatment meeting grants therapeutics
Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-09-15 (Crawled : 19:00) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
| Email alert
Add to watchlist
nasdaq direct offering therapeutics
Hoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-09-13 (Crawled : 20:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 16.04%
H: 8.36%
C: -38.26%
nasdaq direct offering therapeutics
Hoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemia
Published: 2023-09-13 (Crawled : 13:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 16.04%
H: 8.36%
C: -38.26%
tumors positive cancer gastrointestinal leukemia therapeutics results
Hoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patients
Published: 2023-09-11 (Crawled : 14:00) - prnewswire.com
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: -0.81%
H: 16.39%
C: 11.07%
fda drug cancer treatment therapeutics submission
Hoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexa
Published: 2023-09-06 (Crawled : 14:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 4.61%
H: 2.2%
C: 0.88%
positive trial therapeutics results
Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease
Published: 2023-08-09 (Crawled : 17:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 8.89%
H: 2.04%
C: 2.04%
disease positive treatment preclinical alzheimer's therapeutics ht-alz results
Hoth Therapeutics Announces Major Milestone of First Patient Dosed in Phase 2a Clinical Trial
Published: 2023-07-25 (Crawled : 13:00) - biospace.com/
HOTH | $1.21 0.83% 0.0% 75K
|
Health Technology
|
| O: 1.15%
H: 2.27%
C: 1.89%
trial therapeutics milestone
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.